-
Executive Summary
-
Research Scope & Segmentation
- Research Objectives
- Limitations & Assumptions
- Market Scope & Segmentation
- Currency & Pricing Considered
-
Market Opportunity Assessment
- Emerging Regions / Countries
- Emerging Companies
- Emerging Applications / End Use
-
Market Trends
- Drivers
- Market Warning Factors
- Macro Economic Indicators
- Geopolitical Impact
- Technology Factors
-
Market Assessment
- Porters Five Forces Analysis
- Value Chain Analysis
-
mRNA Vaccines and Therapeutics Market Size Analysis
- Introduction
- mRNA Vaccines and Therapeutics Market Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
-
COVID-19 mRNA vaccines
-
Commercialized Vaccines
-
Pipeline Vaccines
-
Non-COVID-19 mRNA vaccines
-
Oncology
-
Infectious Diseases
-
Other Diseases
- mRNA Vaccines and Therapeutics Market Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
-
COVID-19
-
Nucleoside-Modified mRNA (modRNA)
-
Unmodified mRNA
-
Self-Amplifying mRNA
-
Non-COVID-19
-
Nucleoside-Modified mRNA (modRNA)
-
Unmodified mRNA
-
Self-Amplifying mRNA)
-
North America mRNA Vaccines and Therapeutics Market Size Analysis
- Introduction
- mRNA Vaccines and Therapeutics Market Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
-
COVID-19 mRNA vaccines
-
Commercialized Vaccines
-
Pipeline Vaccines
-
Non-COVID-19 mRNA vaccines
-
Oncology
-
Infectious Diseases
-
Other Diseases
- mRNA Vaccines and Therapeutics Market Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
-
COVID-19
-
Nucleoside-Modified mRNA (modRNA)
-
Unmodified mRNA
-
Self-Amplifying mRNA
-
Non-COVID-19
-
Nucleoside-Modified mRNA (modRNA)
-
Unmodified mRNA
-
Self-Amplifying mRNA)
- U.S. mRNA Vaccines and Therapeutics Market Size Analysis
- Introduction
- mRNA Vaccines and Therapeutics Market Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
-
COVID-19 mRNA vaccines
-
Commercialized Vaccines
-
Pipeline Vaccines
-
Non-COVID-19 mRNA vaccines
-
Oncology
-
Infectious Diseases
-
Other Diseases
- mRNA Vaccines and Therapeutics Market Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
-
COVID-19
-
Nucleoside-Modified mRNA (modRNA)
-
Unmodified mRNA
-
Self-Amplifying mRNA
-
Non-COVID-19
-
Nucleoside-Modified mRNA (modRNA)
-
Unmodified mRNA
-
Self-Amplifying mRNA)
- Canada mRNA Vaccines and Therapeutics Market Size Analysis
- Introduction
- mRNA Vaccines and Therapeutics Market Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
-
COVID-19 mRNA vaccines
-
Commercialized Vaccines
-
Pipeline Vaccines
-
Non-COVID-19 mRNA vaccines
-
Oncology
-
Infectious Diseases
-
Other Diseases
- mRNA Vaccines and Therapeutics Market Market Size & Forecast By mRNA type 2022-2034 (USD MILLION/ Units)
-
COVID-19
-
Nucleoside-Modified mRNA (modRNA)
-
Unmodified mRNA
-
Self-Amplifying mRNA
-
Non-COVID-19
-
Nucleoside-Modified mRNA (modRNA)
-
Unmodified mRNA
-
Self-Amplifying mRNA)
-
Europe mRNA Vaccines and Therapeutics Market Size Analysis
-
APAC mRNA Vaccines and Therapeutics Market Size Analysis
-
Middle East and Africa mRNA Vaccines and Therapeutics Market Size Analysis
-
LATAM mRNA Vaccines and Therapeutics Market Size Analysis
- Competitive Landscape
- mRNA Vaccines and Therapeutics Market Share By Players
- M&A Agreements & Collaboration Analysis
- Tier Structure Analysis
- Recent Developments
- Market Players Assessment
- Arcturus Therapeutics Holdings Inc
- Overview
- Business Information
- Revenue
- ASP
- SWOT Analysis
- Recent Developments
- BioNTech SE
- Daiichi Sankyo Company
- CureVac N.V
- Limited
- ethris GmbH
- GlaxoSmithKline plc
- Gennova Biopharmaceuticals Ltd
- Genova Biopharmaceuticals Ltd
- Moderna Inc
- Panthera Therapeutics GmbH
- Providence Therapeutics
- Silence Therapeutics
- Research Methodology
- Research Data
- Secondary Data
- Major Secondary Sources
- Key Data from Secondary Sources
- Primary Data
- Key Data from Primary Sources
- Breakdown of Primaries
- Secondary And Primary Research
- Key Industry Insights
- Market Size Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Projection
- Research Assumptions
- Assumptions
- Limitations
- Risk Assessment
- Appendix
- Discussion Guide
- Customization Options
- Related Reports
- Disclaimer